Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is ongoing to evaluate Huaier Granule for idiopathic membranous nephropathy, with recruitment currently in progress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huaier Granule

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Nephropathy, Glomerular Diseases | Phase 4 | Status: RECRUITING